Loading clinical trials...
Loading clinical trials...
Educational Programs Based on Healthy Habits to Improve Quality of Life and Psychosocial Profile in Women With Neurodegenerative Diseases: The ADVICE Protocol Study
This phase of the project aims to analyze the interaction between physical exercise and the phases of the menstrual cycle, evaluating its impact on fatigue, functional capacity, and exercise perception in women with and without Multiple Sclerosis. To achieve this, a controlled, single-blind, prospective, 2x3 crossover, randomized clinical trial will be conducted, involving women with Multiple Sclerosis (MS), matched by age, lifestyle habits (smoking, physical activity), and geographic location with a group of women without MS. This study, aligned with previous findings, seeks to deepen the understanding of the role of exercise in managing Multiple Sclerosis symptoms and to promote greater adherence to personalized physical activity programs adapted to the phases of the menstrual cycle.
Age
18 - 50 years
Sex
FEMALE
Healthy Volunteers
Yes
Hospital Universitario Virgen de la Arrixaca
Murcia, Murcia, Spain
Start Date
December 15, 2024
Primary Completion Date
June 30, 2025
Completion Date
February 15, 2026
Last Updated
December 23, 2025
30
ESTIMATED participants
Strength training session during Early Follicular Phase
OTHER
Strength Training Protocol during Late Follicular Phase
OTHER
Strength Training during Mid-Luteal Phase
OTHER
Lead Sponsor
Universidad de Almeria
Collaborators
NCT07376772
NCT06884579
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07233902